AXL and gastric cancer: Inhibition of AXL, whether through genetic methods or pharmacological inhibitors like BGB324, can significantly diminish CAF-induced aggressiveness in GC cells, resulting in reduced cell motility, viability, and expression of markers linked to EMT [30].